Sunstone på vej med ny life science fond på 150 mio. Euro

Første closing ventes til sommer. Salget af Prexton til Lundbeck har styrket Sunstones investeringscase.
Managing partner i Sunstone Capital, Peter Benson | Photo: Sunstone Capital / PR
Managing partner i Sunstone Capital, Peter Benson | Photo: Sunstone Capital / PR
Af CARSTEN STENO

Sunstone Capital er gået i gang med at rejse kapital til en ny fjerde life science fond. Målet er 150 mio. euro.  Sunstone Capital håber at kunne lave en first closing på den nye fond til sommer og at kunne lukke den helt for nye investorer i begyndelsen af 2019.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading